SOLBRI Trademark

Trademark Overview


On Tuesday, May 10, 2011, a trademark application was filed for SOLBRI with the United States Patent and Trademark Office. The USPTO has given the SOLBRI trademark a serial number of 85317171. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 1, 2016. This trademark is owned by Valeant International (Barbados) SRL. The SOLBRI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of skin disorders, diseases, conditions and ailments; pharmaceutical preparations and products for use in dermatology; antifungal preparations; pharmaceutical preparations and substances for the treatment of eye disorders, diseases, conditions and ailments; pharmaceutical preparations and products for ophthalmological use; pharmaceutical preparations and substances for the treatment of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety, depression, depressive disorders and mental illness; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardiovascular system; pharmaceutical preparations and subst...
solbri

General Information


Serial Number85317171
Word MarkSOLBRI
Filing DateTuesday, May 10, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 1, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 6, 2014

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of skin disorders, diseases, conditions and ailments; pharmaceutical preparations and products for use in dermatology; antifungal preparations; pharmaceutical preparations and substances for the treatment of eye disorders, diseases, conditions and ailments; pharmaceutical preparations and products for ophthalmological use; pharmaceutical preparations and substances for the treatment of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety, depression, depressive disorders and mental illness; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardiovascular system; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations and substances for the treatment of infectious diseases; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations and substances for use in chemotherapy; pharmaceutical preparations and substances for use in urology; pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for controlling insulin levels; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, anti-inflammatories and pain relief medication; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances for the treatment of fungal infections, onychomycosis, tinea infections, and similar diseases of the skin and nails; pharmaceutical preparations and substances for use in dermatological conditions

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 16, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameValeant International Bermuda
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressHamilton HM11
BM

Party NameValeant International (Barbados) SRL
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressChrist Church BB17154
BB

Party NameValeant International (Barbados) SRL
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressChrist Church BB17154
BB

Trademark Events


Event DateEvent Description
Monday, August 1, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 1, 2016ABANDONMENT - NO USE STATEMENT FILED
Thursday, March 3, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 20, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 19, 2016EXTENSION 3 GRANTED
Monday, December 21, 2015EXTENSION 3 FILED
Monday, December 21, 2015TEAS EXTENSION RECEIVED
Tuesday, July 14, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, July 11, 2015EXTENSION 2 GRANTED
Monday, June 29, 2015EXTENSION 2 FILED
Monday, June 29, 2015TEAS EXTENSION RECEIVED
Thursday, February 19, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 18, 2015EXTENSION 1 GRANTED
Thursday, December 18, 2014EXTENSION 1 FILED
Thursday, February 12, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 21, 2015ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, December 18, 2014TEAS EXTENSION RECEIVED
Tuesday, July 1, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 6, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 6, 2014PUBLISHED FOR OPPOSITION
Wednesday, April 16, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 1, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, April 1, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 13, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 12, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 12, 2014TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, January 22, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 22, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 30, 2013NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, September 30, 2013FINAL REFUSAL E-MAILED
Monday, September 30, 2013FINAL REFUSAL WRITTEN
Thursday, September 12, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 12, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 11, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 18, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 18, 2013NON-FINAL ACTION E-MAILED
Monday, March 18, 2013NON-FINAL ACTION WRITTEN
Thursday, March 7, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 7, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 27, 2013TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, August 28, 2012NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, August 28, 2012INQUIRY TO SUSPENSION E-MAILED
Tuesday, August 28, 2012SUSPENSION INQUIRY WRITTEN
Monday, August 27, 2012LIE CHECKED SUSP - TO ATTY FOR ACTION
Monday, August 27, 2012ASSIGNED TO LIE
Wednesday, August 1, 2012ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, February 24, 2012NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, February 24, 2012LETTER OF SUSPENSION E-MAILED
Friday, February 24, 2012SUSPENSION LETTER WRITTEN
Thursday, February 23, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 23, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 23, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 24, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 24, 2011NON-FINAL ACTION E-MAILED
Wednesday, August 24, 2011NON-FINAL ACTION WRITTEN
Wednesday, August 24, 2011ASSIGNED TO EXAMINER
Monday, May 16, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, May 13, 2011NEW APPLICATION ENTERED IN TRAM